3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
7
Surgical Wound Infection
5
Pilonidal Sinus
3
Wound Infection
2
Sarcoma
2
Thyroid Nodule
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Spinal Cord Injuries
1
Skin Neoplasms
1
Skin Carcinoma
1
Seroma
1
Postoperative Complications
1
Obesity
1
Non-melanoma Skin Cancer
1
Neoplasm Metastasis
1
Infections
1
Graves Disease
1
Goiter
1
Adenocarcinoma
1
Interventions
pembrolizumab
23
Nivolumab
22
aldesleukin
21
Cyclophosphamide
20
Ipilimumab
17
Interleukin-2
17
fludarabine
15
fludarabine phosphate
14
cemiplimab
12
Radiotherapy
7
Fluorouracil
7
Dacarbazine
6
binimetinib
5
Vemurafenib
5
Temozolomide
5
Surgical Procedures, Operative
5
Sirolimus
5
Radiation
5
Biopsy
5
Aminolevulinic Acid
5
encorafenib
4
dabrafenib
4
Photochemotherapy
4
Educational Status
4
trametinib
3
sonidegib
3
montanide ISA 51
3
avelumab
3
Tacrolimus
3
Sodium Chloride
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Skin Neoplasms
×
Negative-Pressure Wound Therapy
×
Clear all
NCT07040683
2026-05-28
LEGS
Region Skane
Phase NA
Recruiting
242 enrolled